|
KMID : 1161420190220030277
|
|
Journal of Medicinal Food
2019 Volume.22 No. 3 p.277 ~ p.285
|
|
|
Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo
|
|
Leem Eun-Ju
Oh Yong-Seok
Shin Won-Ho
Jin Byung-Kwan
Jeong Jae-Yeong
Shin Min-Sang
Kim Dong-Woon
Jang Jin-Hyeok
Kim Hyung-Jun
Ha Chang-Man
Jung Un-Ju
Moon Gyeong-Joon
Kim Sang-Ryong
|
|
|
Abstract
|
|
|
|
Parkinson's disease (PD) and Alzheimer's disease exhibit common features of neurodegenerative diseases and can be caused by numerous factors. A common feature of these diseases is neurotoxic inflammation by activated microglia, indicating that regulation of microglial activation is a potential mechanism for preserving neurons in the adult brain. Recently, we reported that upregulation of prothrombin kringle-2 (pKr-2), one of the domains that make up prothrombin and which is cleaved and generated by active thrombin, induces nigral dopaminergic (DA) neuronal death through neurotoxic microglial activation in the adult brain. In this study, we show that silibinin, a flavonoid found in milk thistle, can suppress the production of inducible nitric oxide synthase and neurotoxic inflammatory cytokines, such as interleukin-1β and tumor necrosis factor-α, after pKr-2 treatment by downregulating the extracellular signal-regulated kinase signaling pathway in the mouse substantia nigra. Moreover, as demonstrated by immunohistochemical staining, measurements of the dopamine and metabolite levels, and open-field behavioral tests, silibinin treatment protected the nigrostriatal DA system resulting from the occurrence of pKr-2-triggered neurotoxic inflammation in vivo. Thus, we conclude that silibinin may be beneficial as a natural compound with anti-inflammatory effects against pKr-2-triggered neurotoxicity to protect the nigrostriatal DA pathway and its properties, and thus, may be applicable for PD therapy.
|
|
|
KEYWORD
|
|
|
microglia, neurodegeneration, nigrostriatal dopaminergic system, prothrombin kringle-2, silibinin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|